SK life science Announces FDA Clearance of IND Application f

SK life science Announces FDA Clearance of IND Application for its Oncology Candidate, SKL27969, a PRMT5 Inhibitor for the Potential Treatment of Advanced Solid Tumors

/PRNewswire/ -- SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company, announced that the U.S....

Related Keywords

Marc Kamin , Sk Life Science Inc , Sk Group , Sk Biopharmaceuticals Co Ltd , Source Sk Life Science Inc , Drug Administration , Sk Inc , Jeong Woo Cho , Sk Life Science , Nc ,